Pfizer Inc PFE:NYSE (Common Stock)

LastDaily Change / % ChangeDividend YieldVolumeAvg Volume (10 day)
34.06 0.18   0.53%3.76%1324.5M
Market data is delayed by at least 15 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 6/22/2017

Latest News Headlines for Pfizer Inc

Pfizer Declares 32-Cent Third-Quarter 2017 Dividend

NEW YORK--(BUSINESS WIRE)--June 22, 2017-- The board of directors of Pfizer Inc. today declared a 32-cent third-quarter 2017 dividend on the company's common stock, payable September 1, 2017, to shareholders of record at the close of business on August 4, 2017. The third-quarter 2017 cash dividend will be the 315(th) consecutive quarterly dividend paid by Pfizer.

S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017

- Q1 2017 repurchases is 1.6% less than Q4 2016 and 17.5% less than Q1 2016 NEW YORK, June 21, 2017 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") today announced preliminary results indicating that S&P 500(R) stock buybacks, or share repurchases, totaled $133.1 billion for Q1 2017. This is a 1.6% decrease from the $135.3 billion reported for Q4 2016 and a 17.5% decrease from the $161.4 billion reported for Q1 2016, when companies actively supported declining share prices.

S&P 500 Buybacks Fall 17.5% Year-over-Year to -2-

Consumer Staples $14,469 $11,615 $11,708 $46,200 $45,725 $223,617 Energy $2,107 $979 $2,053 $5,816 $11,765 $130,584 Financials $29,497 $26,772 $26,706 $107,148 $98,737 $405,830

View more recent headlines

Peers Information HelpPFE Pfizer Inc vs. Peers

Pfizer Inc
Roche Holding Ltd. (ADR)
Novartis AG (ADR)
Merck & Co., Inc.
Bayer AG (ADR)
Pfizer Inc
Roche Holding Ltd. (ADR)
Novartis AG (ADR)
Merck & Co., Inc.
Bayer AG (ADR)
Pfizer Inc
Roche Holding Ltd. (ADR)
Novartis AG (ADR)
Merck & Co., Inc.
Bayer AG (ADR)
Compare these stocks

Latest Annual and Quarterly SEC Filings

More Filings

This report contains detailed information about the company's business finances and management.


Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines, as well as products for consumer healthcare. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.


collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open33.95
Previous Close34.06
Day High34.48
Day Low33.92
52 Week High8/1/2016 | 37.39
52 Week Low11/3/2016 | 29.83
% Off 52 Week High(8.91)%
% Off 52 Week Low14.18%
Beta (5 Yr)0.99
Volatility Avg6/22/2017 | 15.77
10-Day Avg. Volume24,488,354
Market data is delayed by at least 15 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)4/2/2017 | 1.19
P/E Ratio4/2/2017 | 28.5
Market CapMega Cap | 202.83B
Shares Outstanding5.96B

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield3.76%
Dividend Announcement4/27/2017
Date of Record5/12/2017
Payable$0.32 - QRTR
Payable Date6/1/2017

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short45.71M
Short Ratio1.9
Short % of Float0.77%
As of 5/31/2017
The performance data quoted represents past performance. Past performance does not guarantee future results. Current performance may be lower or higher than the performance quoted. Investment return and principal value of an investment will fluctuate and when redeemed, the investment may be worth more or less than their original cost.
The research, tools, and information provided will not include every security available to the public.